The performance of companies tied to flagship drugs like Viagra presents a complex investment landscape . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the expiry in key markets has introduced substantial uncertainty . Investors are now grappling with the impact of generic competition